Sarepta Therapeutics Announces Third Quarter 2019 Financial Results and Recent Corporate Developments
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2019. “EXONDYS 51® (eteplirsen) enjoyed another strong quarter, with third quarter 2019 revenues of $99.0 million, a 26% increase over the same quarter in 2018. Based on current performance, we have raised our full-year 2019 guidance from a range of $365 to $375 million to $370 to $380 million,” stated Doug Ingram, Sarepta’s President and CEO. Mr. Ingram continued, “We have also made significant progress advancing our gene therapy platform. In the quarter, we increased the study enrollment size of our current double-blind, placebo-controlled trial, significantly increasing study power. We are now actively screening and dosing patients at two sites, with the goal of completing all dosing by year end. We have also made progress on gene therapy manufacturing capacity, analy
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- Exploring 3 High Growth Tech Stocks in United States [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch For Potential Investment [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Explore In November 2024 [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks Featuring ALSO Holding And 2 More [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch In The Current Market [Yahoo! Finance]Yahoo! Finance
SRPT
Earnings
- 11/6/24 - Beat
SRPT
Sec Filings
- 11/14/24 - Form SC
- 11/13/24 - Form SC
- 11/6/24 - Form 10-Q
- SRPT's page on the SEC website